Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
3
50%
Ph phase_3
1
17%
Ph phase_4
2
33%

Phase Distribution

0

Early Stage

3

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
3(50.0%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(2)
Other(1)

Detailed Status

Recruiting3
Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (50.0%)
Phase 31 (16.7%)
Phase 42 (33.3%)

Trials by Status

recruiting350%
unknown117%
completed233%

Recent Activity

3 active trials
Showing 5 of 6
recruitingphase_4

Meloxicam in Mohs Micrographic Surgery

NCT07200544
recruitingphase_4

Efficacy of Methylprednisolone for Pain Control After ACL Repair

NCT07158476
recruitingphase_2

Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days

NCT05695352
unknownphase_3

Does Meloxicam Provide as Much Pain Relief as Opioids After Shoulder Surgery?

NCT04725357
completedphase_2

Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea

NCT02183025
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07200544Phase 4

Meloxicam in Mohs Micrographic Surgery

Recruiting
NCT07158476Phase 4

Efficacy of Methylprednisolone for Pain Control After ACL Repair

Recruiting
NCT05695352Phase 2

Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days

Recruiting
NCT04725357Phase 3

Does Meloxicam Provide as Much Pain Relief as Opioids After Shoulder Surgery?

Unknown
NCT02183025Phase 2

Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea

Completed
NCT02183051Phase 2

Study to Compare the the Analgesic Efficacy and Tolerability of Meloxicam Versus Placebo and Ibuprofen in the Treatment of Pain After Surgery of the Third Molar

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6